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Psychostimulants like Adderall and Ritalin are widely used for cognitive enhancement
by people without ADHD, although the empirical literature has shown little conclusive
evidence for effectiveness in this population. This paper explores one potential explanation
of this discrepancy: the possibility that the benefit from enhancement stimulants is at least
in part motivational, rather than purely cognitive. We review relevant laboratory, survey,
and interview research and present the results of a new survey of enhancement users
with the goal of comparing perceived cognitive and motivational effects. These users
perceived stimulant effects on motivationally-related factors, especially “energy” and
“motivation,” and reported motivational effects to be at least as pronounced as cognitive
effects, including the effects on “attention.”
Keywords: cognitive enhancement, prescription stimulants, Adderall, Ritalin, motivation
INTRODUCTION
Stimulant medications such as amphetamine and methy-
phenidate have long been used by healthy individuals to enhance
work performance (see Rasmussen, 2008, for a history). These
medications are currently widely used as study aids by college
students in the US and Canada (Poulin, 2007; Smith and Farah,
2011) and, to a lesser extent, in many other countries (Sahakian
and Morein-Zamir, 2007; Franke, 2011; Castaldi et al., 2012;
Partridge et al., 2013), providing a non-hypothetical case in point
for neuroethical analyses of cognitive enhancement. It is therefore
surprising that a growing number of researchers now question
whether these medications do, in fact, enhance cognition (for
reviews, see Advokat, 2010; Chamberlain et al., 2010; Hall and
Lucke, 2010; Repantis et al., 2010; Smith and Farah, 2011). In
particular, comprehensive reviews of the literature on stimu-
lants’ effects on healthy cognition have noted that there is “very
weak evidence that putatively neuroenhancing pharmaceuticals
in fact enhance cognitive function.” (Hall and Lucke, 2010), even
proposing “that stimulants may actually impair performance on
tasks that require adaptation, flexibility and planning” (Advokat,
2010). We carried out a double-blind, placebo-controlled study
on the effects of mixed amphetamine salts (Adderall), which was
adequately powered to find medium effects. Based on our own
failure to find a single drug effect across numerous measures of
executive functions, memory, creativity, intelligence, and stan-
dardized test performance, we concluded that Adderall “has no
more than small effects on cognition in healthy young adults”
(Ilieva et al., 2013).
This raises the question of why people persist in using
stimulants to enhance schoolwork and, according to anecdo-
tal evidence, other cognitively demanding duties such as stock
trading, entrepreneurship, surgery, and professional academic
work (Sahakian and Morein-Zamir, 2007; Franke et al., 2013;
Kolker, 2013). It may be that a small cognitive advantage is use-
ful in these situations and that is all users seek with continued
use. Alternatively, it may be that individual differences result in
sizeable cognitive advantages for some users, and they are the
ones who use regularly. A third possibility is that users gain
a non-cognitive advantage that helps them perform better in
school and on the job. This is the alternative to be explored in
this review.
STIMULANTS, COGNITION, AND MOTIVATION
The question of whether stimulant-related positive affective states
would impact the performance of cognitive tasks implies a dis-
tinction between motivation and cognition and the role for each
in work performance. Because these terms have received various
definitions in the past, we begin by specifying the sense in which
we use them in the present paper.
By cognition we mean the processes of encoding, storing,
andmanipulating information. Attention, memory, and executive
function are examples of cognitive processes by this general defi-
nition. By cognitive ability we therefore mean the ability to carry
out these processes, which varies among normal healthy people.
We will use the term motivation to refer to a similarly broad
set of affective states that influence whether a person will vol-
untarily use their cognitive ability in the performance of a task.
By this general definition, a number of factors (which often,
but not always, co-occur) reflect or contribute to task motiva-
tion: namely, wanting to complete a task, enjoying it or being
interested in it. Motivation may also be supported by closely
related factors, such as positive mood, alertness, energy, and
the absence of anxiety. Although motivation is a state, there are
trait-like differences in the motivational states that people typ-
ically bring to tasks, just as there are differences in cognitive
ability.
These definitions of cognition and motivation correspond
to the “can’t/won’t” distinction. The performance of cognitively
demanding tasks are subject to limitations of cognitive ability,
as when a subject can’t perform beyond a certain level, and
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limitations of motivation, as when a subject won’t make the effort
to perform beyond a certain level. This distinction is admittedly
somewhat vague and intuitive, rather than precise and analytic,
but we know of no better way of distinguishing between cognition
and motivation in this context.
Objective evidence that cognitive ability is only minimally
enhanced by stimulants comes from tasks in which motivation is
minimally taxed, as these tasks are typically tedious and rewarded
for completion (e.g., in a representative study from our lab, par-
ticipants completed about 2 h of neuropsychological tests, such
as Flanker, Go/No-Go, and NBack, while being compensated
uniformly regardless of performance, Ilieva et al., 2013). It is pos-
sible that stimulants enhance schoolwork and other cognitively
demanding work in everyday contexts where there is larger room
for motivated work: where tasks are more intellectually engag-
ing, where reward depends on performance, and where outcomes
determine users’ future employability and reputation. To explore
here the prediction that users view stimulants’ benefits on moti-
vation as equal or greater than those on cognition, we begin by
reviewing the laboratory literature on stimulants’ effects, as well
as enhancement users’ self-reported reasons for using stimulants
in real-world settings.
STIMULANT EFFECTS ON MOTIVATION: LABORATORY AND CLINICAL
CONSIDERATIONS
Animal research provides ample evidence that the mesolimbic
dopamine system is central to motivation (Koob, 1996; Berridge,
2007; Faure et al., 2008) and stimulant medications are known
to increase activity in this system (Butcher et al., 1988; Drevets
et al., 2001; Volkow et al., 2004). The first psychological effects
of these drugs noted by researchers were increased energy, drive,
enjoyment, and motivation (Rasmussen, 2008). Stimulants are
currently used to treat apathy in neurological and psychiatric
patients (Roth et al., 2007). On the basis of these facts one
would expect an effect of stimulants on motivation in normal,
healthy humans performing cognitive tasks. Although relatively
little research has investigated this directly, the existing evidence
is consistent with this expectation.
Wardle and de Wit (2012) studied the effect of amphetamine
on task enjoyment. Healthy normal subjects were shown pho-
tographs from the International Affective Pictures set and asked
to rate their reactions to the stimuli in terms of emotional
valence and degree of arousal. The drug increased subjects’
enjoyment of all pictures, as assessed by self-report. For pos-
itive pictures, subjects also showed enhanced enjoyment by a
decreased EMG-measured reaction of the corrugator (“frown”)
muscle and elevated reaction of the zygomatic (“smile”) mus-
cle. Thus, these findings corroborated stimulants’ effect on
increased liking for task-related material, a factor contributing to
motivation.
Another way to operationalize motivation is through the
amount of work invested to obtain a reward. A recent double-
blind placebo-controlled study asked whether amphetamine
increased the expenditure of effort for reward. Participants were
given a sequence of choices between a high-effort task promising
large monetary compensation and a less effortful, less profitable
task. The low-effort task required participants to push a button
repeatedly with their index finger, while the high-effort task
entailed a longer duration of button-pressing, using one’s pinky
finger. The probability of reward also varied across trials, with the
result that some trials offered an uncertain chance of high reward
for high effort, thus demanding high motivation. Amphetamine
increased the proportion of high reward/high effort choices.
These results imply that amphetamine may enhance the moti-
vation to work for uncertain rewards where the lack of guaran-
tee of reward would be expected to tax motivation maximally
(Wardle et al., 2011).
Finally, several research groups have noted that subjects find
stimulants particularly rewarding when combined with perfor-
mance of a cognitive task compared to the stimulant with
no cognitive task or the cognitive task without a stimulant.
For example, after trying amphetamine and a benzodiazepine,
subjects chose to combine amphetamine with an attention
task but not with a relaxation task (Silverman et al., 1994a).
Subjects rated a mathematical task as more “interesting” when
performed with methylphenidate, and showed disproportion-
ate striatal dopamine release when math was performed with
the drug, compared to no math or no drug (Volkow et al.,
2004). Finally, subjects were more willing to work to earn
methylphenidate for use while performing a math task, com-
pared to for use during a relaxation session (Stoops et al., 2005).
Similar findings have been obtained with caffeine (Silverman
et al., 1994b) and the novel stimulant modafinil (Stoops et al.,
2005).
MOTIVATIONAL EFFECTS IN ENHANCEMENT USES OF STIMULANTS
The question arises whether stimulants’ motivation-elevating
influence remains robust in real-world contexts, where the setting
and nature of work may be very different from laboratory tasks of
motivation.
Most evidence on this issue is indirect. The role of non-
cognitive factors in the use of stimulants for enhancement is
hinted at by the elevated rates of depression and anxiety among
students who use them (e.g., Weyandt et al., 2009; Rabiner et al.,
2010; Teter et al., 2010; Dussault and Weyandt, 2013). This is
consistent with students self-medicating for psychological dis-
tress or apathy in order to overcome emotional barriers to work
performance. Of course, the causal relations among depression,
academic performance, and stimulant use are likely to be com-
plex (Ford and Schroeder, 2008) rendering these findings only
suggestive at best.
Surveys of students’ reasons for using stimulants also indi-
cate a role for non-cognitive factors, but the multiple-choice
alternatives offered have not been designed to separate the roles
of cognitive and motivational effects in academic performance
enhancement. Rather, they probe for reasons related to social-
izing, recreational drug usage and academic concerns, without
distinguishing the roles of cognitive and motivational effects on
this last category of reasons. Results indicate that students are
sensitive to the non-cognitive effects and exploit them outside of
schoolwork. For example, students report such reasons as get-
ting “high” and having “fun” (Teter et al., 2005, 2006; Boyd
et al., 2006; DeSantis et al., 2008, 2009; Judson and Langdon,
2009; Rabiner et al., 2009; Clegg-kraynok et al., 2011; Dussault
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and Weyandt, 2013). Students note mood-elevating potential
of stimulants (Carroll et al., 2006; Rabiner et al., 2009). When
the surveys include response choices such as “energy” or “alert-
ness” in their list of reasons for using stimulants, high response
rates for these items are found (e.g., Hall et al., 2005; Teter
et al., 2005, 2006; Boyd et al., 2006; Carroll et al., 2006; Judson
and Langdon, 2009; Clegg-kraynok et al., 2011; Peterkin et al.,
2011; Dussault and Weyandt, 2013). Two surveys included one
item each that directly probed motivational effects in relation
to schoolwork: DeSantis et al. (2008) included “to make work
more interesting” and Bavarian et al. (2013) included “to make
studying more enjoyable” in their list of reasons and found
12 and 58% of their respondents, respectively, endorsed these
items.
Vrecko (2013) took a different approach to understanding
students’ reasons for using stimulants as study aids, conducting
open-ended interviews with 24 university students and former
students who identified themselves as users of Adderall for aca-
demic enhancement. Qualitative data analyses showed that users
highlighted stimulants’ positive influence on mood, energy, and
other motivation-related states. Typical statements were “[on
Adderall] I didn’t want to stop what I was doing until it was
completed up to a certain level of my satisfaction,” and “You’re
interested in what you’re doing even if it’s boring.” One respon-
dent summed up the cognitive vs. motivational effect this way:
“Adderall doesn’t necessarily make you smarter [. . .], the main
benefit, really, is that on it, I don’t mind doing work.” Vrecko
concluded that “alteration of emotions appears to be an impor-
tant dimension of the drug effects that users perceive to enable
improved academic performance.”
In sum, while stimulants’ objectively measured effects on
cognition are small, users tend to report substantial perceived
enhancement effects. In this paper we call into question the
assumption that these sizeable perceived effects are purely cogni-
tive. Evidence frommany sources is consistent with the hypothesis
that the motivational effects of stimulants are at least as impor-
tant as the cognitive effects in enhancing students’ academic
performance. However, with the exception of Vrecko’s qualita-
tive research, this evidence comes from research with animals
and clinical populations and simple laboratory tasks, or from
surveys containing just one relevant response option. No study
has directly compared the perceived motivational advantage of
these medications to their perceived cognitive benefit. To do so,
we probe a number of cognitive and motivational constructs
and quantify users’ ratings of stimulants’ ability to enhance
them.
Hence, the purpose of the present study was to test, quan-
titatively, the prediction that enhancement users experience
substantial motivational advantages from stimulants and that
these effects are as pronounced as or more pronounced than
the cognitive advantages. College student stimulant users with-
out ADHD were asked to rate the magnitude of enhancement
drugs’ perceived effects on various aspects of motivation and
cognition. Our focus was on the magnitude of the reported
motivational advantages, especially in comparison to the per-
ceived cognitive effects, previously assumed to be the major
driver of use.
METHODS
PARTICIPANTS
Participants were 40 University of Pennsylvania undergradu-
ates with no self-reported history of ADHD who had used
enhancement stimulants at least once in their lives1. Specifically,
10 participants had used a stimulant for enhancement just once, 5
on 2 occasions, 7 on 3–5 occasions, 7 on 6–9 occasions, 4 on 10–19
occasions, 2 on 20–39 occasions, and 5 on 40 or more occasions.
Participants were recruited from psychology classes in exchange
for course credit and agreed to participate in a larger survey osten-
sibly exploring students’ academic behaviors and beliefs. One
hundred and seventy-one potential participants were screened
out of the survey as non-users of enhancement stimulants.
PROCEDURE AND MATERIALS
Participants completed an online survey that assessed
past enhancement use and stimulants’ perceived effects 2.
Enhancement use was measured as the number of occasions of
use in the past month, past academic year, and in one’s lifetime.
The specific prompt, adapted from Teter et al. (2010), read as fol-
lows: “On howmany occasions have you used ADHDmedication
(e.g., Adderall, Ritalin, or other), without a prescription, to help
you do well at school and/or work?”
Students were then asked to rate how helpful they found
ADHD medications for 14 different psychological functions cho-
sen from popular and scholarly descriptions of cognitive enhance-
ment with stimulants. They indicated their answers on a 7-pont
scale from Very Impairing to Very Helpful (where the midpoint
referred to No Effect). Half of the functions presented were
purely cognitive, that is functions that concerned cognitive abil-
ities and did not carry any implication about an individual’s
affective state. These were: focused attention, memory, creativity,
intelligence, ability to multitask, speed of thinking, and abstract
thinking. The other half of the functions were non-cognitive
functions related to motivation in that they support task per-
formance by increasing subjective energy and enjoyment and
decreasing subjective effort and avoidance:motivation, task enjoy-
ment, mood, self-confidence, energy, alertness, and anxiety relief.
Each participant saw these items in a different randomized
sequence.
RESULTS
The main goal of data analysis was to assess enhancement users’
perceptions of the motivational effects of stimulant medications.
1We chose to focus on enhancement use over the lifetime (as opposed to the
past month or the past year) because this approach rendered a maximum
number of participants eligible, and hence allowed greatest statistical power.
Although participants’ frequency estimates over this long periodmay be prone
to imprecision, we had no theoretical reason to restrict our sample to past-
month or past-year users, potentially omitting useful data from use outside of
these periods.
2In addition to stimulants’ perceived effects, these 40 subjects and the other
171 also answered four other sets of questions. They were intended for both
enhancement users and non-users and concerned differences between the
groups in achievement motivation, lay theories of intelligence, and media
multitasking frequency. Because outside the scope of the present paper, these
data are not reported here.
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Analyses therefore focused on ratings of the medications’ effects
on non-cognitive, motivation-related functions. In particular,
we assessed: (1) whether users reported positive effects on
motivation-related functions; (2) whether this overall percep-
tion of motivational enhancement was greater than, less than, or
equivalent to the overall perception of cognitive enhancement in
the narrow sense, assessed by the cognition-related ratings; and
(3) which particular functions within each category were believed
to be significantly enhanced by these users.
Participants found that stimulants were, overall, enhancing of
both motivation-related and cognition-related functions. Linear
composite ratings in each category, with all individual constituent
functions equally weighed, indicated helpfulness (i.e., ratings
exceeded “no effect” by one sample t-tests): t(39) = 11.17, p <
0.01 and t(39) = 8.56, p < 0.01, respectively, two-tailed3.
In a comparison between the enhancing effects of stimulants
on linear composites of motivation and cognition, participants
perceived greater enhancement of functions in the motivational
category, paired-samples t(39) = 2.19, p = 0.04, two-tailed. In
sum, for the sample of functions used in this project, enhance-
ment users of stimulants found that the pills enhanced moti-
vation, and indeed reported that the pills enhanced motivation
significantly more than cognitive ability.
Turning to the individual functions rated, Table 1 shows
the means of the perceived stimulant effects on each function
within the two categories. A cognitive function (attention) was
rated numerically most strongly enhanced by stimulants, but
3We used two-tailed tests throughout our analyses to avoid overlooking unex-
pected scenarios, including the possibility that users may view stimulants as
impairing to a given ability, or the possibility that, as the neuroethics literature
has traditionally suggested, the perceived effects on cognition might outweigh
those on motivation.
it was not rated significantly higher than the next three in
descending order: energy, alertness, and motivation, by paired-
samples t-tests: [t(39) = 0.82, p = 0.42; t(39) = 0.77, p = 0.45;
and t(39) = 0.85, p = 0.40, respectively]. Equivalence testing,
with differences <0.5 points on the 7-point scale stipulated to be
equivalent, suggested that the standard 90% confidence interval
(Walker and Nowacki, 2011) of the difference between the vari-
ables ([−0.13, 0.38], for the attention-energy contrast; [−0.18;
0.48], for the attention-alertness contrast; [−0.15, 0.45], for the
attention-motivation contrast) fell within the equivalence interval
of [−0.50; 0.50]. Taken together, null-hypothesis and equivalence
tests converged to suggest that attention ratings were compara-
ble to the ratings on the three highest rated motivation-related
functions.
Considering all of the functions (motivational and cogni-
tive) examined, most but not all were rated as significantly
enhanced, 12 of the 14 ratings of enhancement significantly
differed from “no effect” using a series of one-sample t-tests
(Table 1). Correcting for multiple comparisons by dividing the
critical p-value of 0.05 by 14, 11 functions remain rated as sig-
nificantly enhanced by this more appropriately conservative cri-
terion. These included 6 motivational functions and 5 cognitive
functions.
These findings remained generally unchanged after (a) exclu-
sion of 2 participants with univariate outlier ratings falling more
than 3 SD away from the mean of the other 40 participants of
the sample and (b) after exclusion of the subsample of 10 partic-
ipants who used stimulants for enhancement only once in their
lifetime4.
4With the exception that, in (b), no evidence for equivalence emerged for the
comparison between ratings of alertness and attention, and only five functions
in the motivation category showed significant perceived enhancement.
Table 1 | Perceived stimulant enhancement effects on motivation and cognition.
Descriptives One-sample t-tests
N Mean perceived effect* Std. Dev. t df Sig. (2-tailed) Mean difference from
“no effect”
COGNITION-RELATED FUNCTIONS
Ability to multitask 40 4.47 1.826 1.646 39 0.108 0.475
Abstract thinking 40 4.75 1.276 3.717 39 0.001 0.750
Attention 40 6.30 1.067 13.633 39 0.000 2.300
Creativity 40 4.45 1.154 2.467 39 0.018 0.450
Intelligence 40 4.98 1.271 4.853 39 0.000 0.975
Memory 40 5.15 1.099 6.618 39 0.000 1.150
Speed of thinking 40 5.78 1.310 8.567 39 0.000 1.775
MOTIVATION-RELATED FUNCTIONS
Alertness 40 6.15 0.864 15.742 39 0.000 2.150
Anxiety relief 40 4.13 1.522 0.519 39 0.606 0.125
Energy 40 6.18 0.874 15.743 39 0.000 2.175
Mood 40 4.78 1.476 3.321 39 0.002 0.775
Motivation 40 6.15 1.075 12.645 39 0.000 2.150
Self-confidence 40 5.13 1.539 4.623 39 0.000 1.125
Task enjoyment 40 5.40 1.482 5.977 39 0.000 1.400
*7, Extremely helpful; 6, Very helpful; 5, Somewhat helpful; 4, No effect; 3, Somewhat impairing; 2, Very impairing; 1, Extremely impairing.
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DISCUSSION
There is an emerging consensus in the literature on cognitive
enhancement that the cognitive benefits of prescription
stimulants are modest. The most commonly used medications
for cognitive enhancement, amphetamine and methylphenidate,
seem to have limited effects on laboratory measures of exec-
utive function and learning in normal, healthy young adults.
Nevertheless, these drugs are widely used to enhance work per-
formance by college students and others engaged in cognitively
demanding work. In the present article we explored the possibil-
ity that these drugs are used to enhance motivation rather than,
or in addition to, cognition.
Recent laboratory evidence suggests that amphetamine and
methylphenidate enhance motivation-related processes in healthy
participants, and the in-depth interviewing conducted by Vrecko
(2013) indicates that enhancement users find the motivational
effects of these drugs helpful for enhancing schoolwork. Here we
add to the laboratory, survey, and interview evidence by perform-
ing the first survey directly comparing users’ ratings of stimulants’
motivation- and cognition-enhancing effects.
The present study found that student users perceive stimulants
as beneficial for cognition, despite the weak evidence for objec-
tive cognitive enhancing effects (see Introduction). However,
student users also perceive stimulants as advantageous for moti-
vation. Motivation, energy, and attention, the functions viewed
as most strongly enhanced, did not differ in their susceptibil-
ity to stimulants’ subjective effects. Not only were motivational
functions found by users to be significantly enhanced, they were
found to be somewhat more enhanced as a group than a cate-
gory of cognitive functions, and this difference was statistically
significant. This finding extends previous knowledge by demon-
strating that stimulants’ motivational effects are viewed by healthy
users as prominent despite the common assumption that they
work chiefly on cognition. Although our study is limited to
assessing perceived enhancement and does not speak to actual
behavioral effects on motivation, cognitive processing, or task
performance, the results document experiential effects relevant to
users’ decisions to practice enhancement with prescription stim-
ulants. According to students who use stimulants for cognitive
enhancement, these drugs may enable better performance of cog-
nitively demanding work at least in part through their effects on
motivation.
These patterns of data emerged despite measurement limi-
tations, including the assessment of enhancement effects over
a lengthy period of time, potentially conducive to recall errors
in participants’ estimates. Future research should address ques-
tions unexamined in the present study, including the possible
moderation of perceived motivational effects by specific medica-
tion (e.g., amphetamine vs. methylphenidate) or dose (high vs.
low). Additionally, further research is needed to show whether the
motivational effects of these drugs are particularly valuable under
conditions of fatigue or sleep deprivation.
The present data support the hypothesis that enhancement
users rely on ADHD medication for boosting drive, energy, and
mood, rather than cognitive capacity alone. Thus, our study
opens up novel avenues for future research. How do individual
differences and different types of academic work moderate the
effects discussed here? How does stimulant-enhanced motivation
affect actual performance? Do the present conclusions, regarding
enhancement uses of stimulants, also apply to therapeutic uses
in neuropsychiatric disorders? What alternative interventions for
improving achievement motivation might be possible, with fewer
risks than prescription stimulants?
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